Reinhard Ruckser

605 total citations
24 papers, 215 citations indexed

About

Reinhard Ruckser is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Reinhard Ruckser has authored 24 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Reinhard Ruckser's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Treatment and Pharmacology (3 papers). Reinhard Ruckser is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Treatment and Pharmacology (3 papers). Reinhard Ruckser collaborates with scholars based in Austria, Germany and United States. Reinhard Ruckser's co-authors include W Hinterberger, Veronika Buxhofer‐Ausch, Christian Sebesta, Wolfgang Schimetta, Bettina Gisslinger, Heinz Gisslinger, K Bauer, Michael Steurer, Günther Gastl and G Haberhauer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Reinhard Ruckser

24 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reinhard Ruckser Austria 10 84 72 63 59 33 24 215
Cassandra P. Loren United States 7 111 1.3× 196 2.7× 50 0.8× 96 1.6× 14 0.4× 8 342
RJ Cooper United States 8 95 1.1× 244 3.4× 51 0.8× 81 1.4× 36 1.1× 10 347
Hien K. Duong United States 8 104 1.2× 261 3.6× 100 1.6× 107 1.8× 12 0.4× 30 425
Melania Carlisi Italy 10 74 0.9× 105 1.5× 68 1.1× 94 1.6× 4 0.1× 38 268
Shashank Jain United States 3 61 0.7× 137 1.9× 142 2.3× 18 0.3× 10 0.3× 7 249
R. H. C. Brons Netherlands 6 73 0.9× 139 1.9× 43 0.7× 85 1.4× 11 0.3× 7 317
G Nalli Italy 9 45 0.5× 252 3.5× 37 0.6× 125 2.1× 11 0.3× 25 371
Kaveh Jaseb Iran 12 96 1.1× 176 2.4× 45 0.7× 132 2.2× 6 0.2× 46 355
Juan Esteban García-Robledo United States 9 68 0.8× 64 0.9× 102 1.6× 42 0.7× 6 0.2× 33 266
Benoît Guillet France 14 110 1.3× 479 6.7× 25 0.4× 146 2.5× 24 0.7× 46 578

Countries citing papers authored by Reinhard Ruckser

Since Specialization
Citations

This map shows the geographic impact of Reinhard Ruckser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinhard Ruckser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinhard Ruckser more than expected).

Fields of papers citing papers by Reinhard Ruckser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reinhard Ruckser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinhard Ruckser. The network helps show where Reinhard Ruckser may publish in the future.

Co-authorship network of co-authors of Reinhard Ruckser

This figure shows the co-authorship network connecting the top 25 collaborators of Reinhard Ruckser. A scholar is included among the top collaborators of Reinhard Ruckser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reinhard Ruckser. Reinhard Ruckser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cheng, et al.. (2022). Kolorektales Karzinom. Wiener Medizinische Wochenschrift. 173(9-10). 216–220. 8 indexed citations
2.
3.
Buxhofer‐Ausch, Veronika, Dominik Wolf‎, Wolfgang Schimetta, et al.. (2020). Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia. European Journal Of Haematology. 106(1). 58–63. 13 indexed citations
4.
5.
Buxhofer‐Ausch, Veronika, Michael Steurer, Wolfgang Schimetta, et al.. (2018). Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia. European Journal Of Haematology. 101(2). 131–135. 12 indexed citations
6.
Steger, Guenther G., Edgar Petru, Ferdinand Haslbauer, et al.. (2016). Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study. Annals of Oncology. 27. vi74–vi74. 2 indexed citations
7.
Buxhofer‐Ausch, Veronika, Michael Steurer, Wolfgang Schimetta, et al.. (2016). Influence of platelet and white blood cell counts on major thrombosis – analysis from a patient registry in essential thrombocythemia. European Journal Of Haematology. 97(6). 511–516. 33 indexed citations
8.
Felzmann, Thomas, Johanna Buchroithner, Christine Marosi, et al.. (2014). A randomized clinical trial for the treatment of glioblastoma multiforme with the individualized dendritic cell-based cancer immunotherapy AV0113.. Journal of Clinical Oncology. 32(15_suppl). 2052–2052. 1 indexed citations
9.
Felzmann, Thomas, Johanna Buchroithner, Christine Marosi, et al.. (2013). Abstract 4658: First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.. Cancer Research. 73(8_Supplement). 4658–4658. 1 indexed citations
10.
11.
Buxhofer‐Ausch, Veronika, Reinhard Ruckser, P Kier, et al.. (2004). A rare case of interstitial pneumonitis after tandem high‐dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma. European Journal Of Haematology. 73(2). 143–146. 2 indexed citations
12.
Hinterberger, W, E Ogris, P Kier, et al.. (2002). [Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].. PubMed. 59. 2–8. 2 indexed citations
13.
Ruckser, Reinhard, P Kier, Christian Sebesta, et al.. (2001). Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia. European Journal Of Haematology. 67(2). 128–132. 6 indexed citations
14.
Hinterberger-Fischer, M, E Ogris, P Kier, et al.. (2000). Elevation of Plasma Prolactin in Patients Undergoing Autologous Blood Stem-Cell Transplantation for Breast Cancer. American Journal of Clinical Oncology. 23(4). 325–329. 6 indexed citations
15.
Ruckser, Reinhard, Jeffrey W. Hofmann, Karen E. Huber, et al.. (1997). Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients.. PubMed. 14(4). 264–72. 8 indexed citations
16.
Ruckser, Reinhard, et al.. (1997). Significant Elevation of Tumour-Associated Isoforms of Soluble CD44 in Serum of Normal Individuals Caused by Cigarette Smoking. Clinical Chemistry and Laboratory Medicine (CCLM). 35(2). 81–4. 10 indexed citations
17.
Haberhauer, G, et al.. (1997). Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis. Rheumatology International. 16(5). 181–186. 31 indexed citations
18.
Sebesta, Christian, P Kier, Reinhard Ruckser, et al.. (1995). ERCP and Balloon Dilation Is a Valuable Alternative to Surgical Biliodigestive Anastomosis in the Long Common Channel Syndrome in Childhood. Endoscopy. 27(9). 709–710. 2 indexed citations
19.
Sebesta, Christian, et al.. (1995). [Possible role of autotransplantation in small cel bronchial carcinoma].. PubMed. 145(2-3). 50–2. 1 indexed citations
20.
Klein, Michael, et al.. (1992). Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen — a case report. Archives of Gynecology and Obstetrics. 252(2). 99–102. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cassandra P. Loren Breakdown of academic impact, for papers by RJ Cooper Breakdown of academic impact, for papers by Hien K. Duong Breakdown of academic impact, for papers by Melania Carlisi Breakdown of academic impact, for papers by Shashank Jain Breakdown of academic impact, for papers by R. H. C. Brons Breakdown of academic impact, for papers by G Nalli Breakdown of academic impact, for papers by Kaveh Jaseb Breakdown of academic impact, for papers by Juan Esteban García-Robledo Breakdown of academic impact, for papers by Benoît Guillet
Rankless by CCL
2026